About Parkwalk
Parkwalk is a venture capital firm founded in 2009. It is primarily based out of London, United Kingdom. As of Oct 2026, Parkwalk is an active investor, having invested in 155 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Seed round of Matter Machine Overall, Parkwalk portfolio has seen 1 unicorn, 8 IPOs and 21 acquisitions including key companies like Cytora, Horizon Discovery and Tracsis. A lot of funds co-invest with Parkwalk, with names like Cambridge Enterprise sharing a substantial percentage of its portfolio. Parkwalk has team of 16 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 4 more
Portfolio IPOs
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Parkwalk's List of Top Investments
Parkwalk has a portfolio of 155 companies, one of which is a Unicorn. Their most notable investments are in Psyomics and Cloud Sustainability.Their portfolio spans across United Kingdom, United States, Mexico and 1 more locations. They have invested in Enterprise Applications, High Tech, Life Sciences and 30 other sectors, across stages such as Seed, Series A and 4 more. Here is the list of top investments by Parkwalk:1. BibliU
Provider of digital learning content and campus store management solutions. The platform offers institutions tools to automate content workflows and improve learning outcomes. It provides digital textbooks, monographs, and courseware. The platform integrates with existing systems to deliver an interactive learning experience. It supports diverse academic needs of students and faculty.
Key facts about BibliU
- Founded Year: 2014
- Location: Greenville (United States)
- Annual Revenue: £50M - £100M as on Oct 31, 2024
- Stage: Series C
- Total Funding till date: $102M
- Employee Count: 201 as on Aug 31, 2026
- Investors: Oxford Science Enterprises, GSP Capital and 28 Others
- Latest Funding Round: Series C, Jun 02, 2026, $*****
- Highlight: Editors' Pick
2. Cytora
Risk management solutions for insurers and underwriters. It provides risk digitization by extraction data points, risk evaluation by evaluating portfolio strategies, and more. It also allows integration of data sources, defining rules, and optimizing risk flows.
Key facts about Cytora
- Founded Year: 2012
- Location: London (United Kingdom)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $41.5M
- Employee Count: 129 as on Sep 30, 2026
- Investors: EQT, Starr Companies and 42 Others
- Latest Funding Round: Series B, Apr 17, 2019, $*****
- Highlight: Acquired
Manufacturer of niobium-based anode material for lithium-ion batteries and cells. The material enables fast charging, long cycle life, and safety for heavy-duty applications. It supplies anode active material to cell manufacturers and demonstrator cells to OEMs for evaluation. The company supports product development with its team of scientists and engineers.
Key facts about Echion Technologies
- Founded Year: 2017
- Location: Sawston (United Kingdom)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $92.4M
- Employee Count: 50 as on Mar 31, 2025
- Investors: Origin Capital, Kima Ventures and 35 Others
- Latest Funding Round: Series B, Nov 14, 2024, $*****
- Highlight: Editors' Pick

4. Oxa
Developer of autonomous software and hardware for industrial vehicle fleets. This technology enables self-driving capabilities for various industrial vehicles through modular hardware systems. The software integrates with fleet management tools to coordinate vehicle operations and logistics. These systems facilitate automated movement within industrial environments to improve operational efficiency.
Key facts about Oxa
- Founded Year: 2014
- Location: Oxford (United Kingdom)
- Annual Revenue: £1M - £10M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $349M
- Employee Count: 357 as on Sep 30, 2026
- Investors: BP Ventures, Hostplus and 26 Others
- Latest Funding Round: Series D, Mar 04, 2026, $*****
- Highlight: Editors' Pick

5. Paragraf
Provider of graphene-based magnetic sensors. It develops graphene solutions using its proprietary two-dimensionally material manufacturing process. Its products portfolio includes graphene-based hall-effect sensors, biosensors, and solid-state devices. Its features include hardness, bendability, and absorbency across UV and visible spectrum.
Key facts about Paragraf
- Founded Year: 2015
- Location: Somersham (United Kingdom)
- Stage: Series C
- Total Funding till date: $140M
- Employee Count: 136 as on Sep 30, 2026
- Investors: Draper Esprit, Molten Ventures and 17 Others
- Latest Funding Round: Series C, Aug 25, 2025, $*****
- Highlight: Editors' Pick
Parkwalk's Year-on-Year Investment Trends
Parkwalk has invested in 155 companies over the last 16 years, with an average of 6 new investments annually in the last 10 years. In 2025, it made 1 investment, while as of Oct 2026, it has made 1 investment in this year. Its most recent first time investment was in Matter Machine and most recent follow-on round was in Brainomix.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 0 | 1 | 1 |
2024 | 2 | 2 | 4 |
2023 | 5 | 6 | 11 |
2022 | 4 | 7 | 11 |
2021 | 4 | 8 | 12 |
2020 | 6 | 9 | 15 |
2019 | 9 | 11 | 20 |
2018 | 12 | 10 | 22 |
2017 | 15 | 7 | 22 |
Parkwalk's Investments by Stage
Parkwalk has made 61 investments in Seed stage with an average round size of $2.29M, 33 investments in Series A stage with an average round size of $5.81M and 11 investments in Series B stage with an average round size of $14.6M.Stage of entry | No. of Investments |
|---|---|
Seed | 61 |
Series A | 33 |
Series B | 11 |
Post IPO | 6 |
PE | 3 |
Others | 3 |
Note: We have considered here, only first round of investments
Parkwalk's Investments by Sector
Parkwalk has a diverse portfolio, with companies operating in the High Tech, Enterprise Applications, Life Sciences, Semiconductors and Sustainability Tech. Notably, it has invested in 137 Tech companies, 134 Enterprise (B2B) companies, 61 Software companies and at least 57 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
High Tech | 42 |
Enterprise Applications | 35 |
Life Sciences | 34 |
Semiconductors | 18 |
Sustainability Tech | 16 |
Others | 108 |
Note: We have considered here, only first round of investments
Parkwalk's Investments by Geography
Parkwalk has made most investments in United Kingdom (108), followed by United States where it has made 4 investments.Country | No. of Investments |
|---|---|
United Kingdom | 108 |
United States | 4 |
Mexico | 1 |
Taiwan | 1 |
Note: We have considered here, only first round of investments
Parkwalk's recent investments
Parkwalk has made 1 investments in 2026 so far - Matter Machine.Here are the most recent investments by Parkwalk:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 12, 2026 | - | Seed | 2754 | [+4] | |
Jan 06, 2025 | United Kingdom | Series C | 9222 | [+1] | |
Oct 30, 2024 | United Kingdom | Series A | 3790 | [+3] | |
Jul 18, 2024 | United Kingdom | Seed | 2924 | [+3] | |
May 02, 2024 | United Kingdom | Seed | 4313 | [+2] |
Unicorns in Parkwalk's Portfolio
Parkwalk has 1 unicorn in its portfolio - Nyobolt. The most recent unicorn in their portfolio is Nyobolt which became a unicorn in 2026.Here is a list of unicorns in Parkwalk's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
55 | Developer of high power integrated energy systems for industrial applications | 2019 | Cambridge | Series C | pyrcavr |
IPOs and Publicly Listed companies in Parkwalk's Portfolio
8 of Parkwalk's portfolio companies have become public. Mirriad got listed on the London Stock Exchange (LSE), in Dec 2017 at marketcap of $85.9M and Hydrofinity got listed on the London Stock Exchange (LSE).Here are Parkwalk's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 19, 2017 | May 2015 | Series C | 2476 | |
Mar 25, 2014 | - | - | 1832 | |
Jul 10, 2012 | Apr 2011 | Series B | 8405 | |
Apr 11, 2011 | Mar 09, 2017 | Post IPO | 2306 | |
May 14, 2010 | Oct 18, 2016 | Post IPO | 1564 |
Acquired companies in Parkwalk's Portfolio
21 companies from Parkwalk's portfolio have been acquired. The most recent acquisition was Cytora in Sep 2025 by Applied for $*****.Here are Parkwalk's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 09, 2025 | Oct 01, 2015 | Series A | 5523 | |
Sep 02, 2025 | Apr 30, 2019 | Series B | 4731 | |
Dec 19, 2024 | Oct 01, 2017 | Post IPO | 8636 | |
Jul 08, 2024 | - | - | 9462 | |
Nov 24, 2023 | - | - | 2344 |
Team profile of Parkwalk
Parkwalk has a team of 16 members including 2 Partners, 1 Venture Partner and 9 Principals located in United Kingdom. Parkwalk's team sits on the board of 1 company.Here is a list of top team members in Parkwalk:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | London | |||
Partner | London | - | ||
Venture Partner | United Kingdom | - | - | |
Principal | London | - | ||
Principal | London | - | ||
Principal | United Kingdom | - | - | |
Principal | United Kingdom | - | - | |
Principal | United Kingdom | - | - | |
Principal | London | - | - | |
Principal | United Kingdom | - | - | |
Principal | - | - |
Co-investors of Parkwalk
Over the past 16 years, 466 investors have co-invested in Parkwalk's portfolio companies. This includes funds and angels.
- Invested before Parkwalk: IP Group, Europa and 119 others have invested in rounds before Parkwalk. There are 10 companies where IP Group has invested before Parkwalk and 5 companies where Europa has invested before Parkwalk.
- Top Co-investors of Parkwalk: 94 investors entered a company along with Parkwalk. These include investors like Cambridge Enterprise (9 companies).
- Invested after Parkwalk: A total of 251 investors have invested in Parkwalk's portfolio after their investments. Top Investors include Parkwalk (34 companies), Europa (14 companies) and BGF (12 companies).
Recent News related to Parkwalk
•
UK's Scripta Therapeutics secures over €10 million to revolutionize drug discoveryEU-Startups•Nov 13, 2025•Oxford Science Enterprises, Apollo Health Ventures, Scripta Therapeutics, YZR Capital and 3 others
•
Startup developing ‘liquid bandages’ raises £4.8mUKTN•Sep 30, 2025•NoBACZ, ACF Investors, University of Cambridge, Cambridge Enterprise and 4 others
•
NoBACZ Healthcare Raises £4.8M in FundingFinSMEs•Sep 30, 2025•NoBACZ, ACF Investors, University of Cambridge, The FSE Group and 3 others
•
Enhanced Genomics Secures €16 Million To Accelerate Therapeutics Pipeline DevelopmentStartup Rise EU•Sep 17, 2025•Meltwind Advisory, Elegen, BGF, Parkwalk
•
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipelineNews Medical•Sep 17, 2025•Meltwind Advisory, BGF, Parkwalk, Enhanced Genomics
•
Cambridge biotechnology company extends Series A funding to $19mInsider Media•Sep 17, 2025•Meltwind Advisory, BGF, Parkwalk, Enhanced Genomics
•
British startup Phasecraft raises €29 million to advance quantum computing solutionsEU-Startups•Sep 02, 2025•PhaseCraft, Plural, Novo Holdings, Playground and 4 others
•
Phasecraft Raises $34M in Series B FundingFinSMEs•Sep 02, 2025•Plural, PhaseCraft, AlbionVC, Parkwalk and 5 others
•
Northern Gritstone & Parkwalk launch Northern Universities Venture Fund.Prolific North•Jun 20, 2025•Parkwalk, Northern Gritstone
•
Northern Gritstone and Parkwalk launch EIS fund for UK science and DeepTech spinoutsEU-Startups•Jun 19, 2025•Northern Gritstone, Parkwalk